Prospective cancer treatment found in the Cowpea Mosaic Virus

Abstract

The Cowpea Mosaic Virus (CPMV) shows encouraging results as an immunotherapy against multiple forms of cancerous cells and tumors. The nanoparticles in the Cowpea Mosaic Virus have been administered to cancer infected mice by in situ vaccination. Not only do the results show improved conditions of the cancerous tumors but in some cases, it completely eliminated the metastases. Furthermore, the Cowpea Mosaic Virus nanoparticles do not impose any viable risk factors or dangerous side effects. Possible future treatment of various malignant tumors may be reliant on direct injection of the Cowpea Mosaic Virus nanoparticles.